SUBSCRIBERS
2 pharma firms to mine gene data from 500,000 Britons
Published Thu, Mar 23, 2017 · 09:50 PM
London
BRITAIN'S GlaxoSmithKline and US-based Regeneron Pharmaceuticals are embarking on a joint project with UK Biobank, the world's most detailed biomedical database, to hunt for new clues linking genes and disease.
By analysing genetic variations and health in 500,000 middle-aged and older Britons, the partners said on Thursday that they hoped to identify promising leads for new medicines.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Starbucks points to weaker consumer as profit falls
Restaurant Brands tops estimates as Burger King overhaul pays off
Walmart to shut all health centers in US over lack of profitability
Coca-Cola raises annual sales forecast on global demand, higher prices
Dying salmon trouble Norway’s vast fish-farm industry
Fast-fashion giant Shein wants to sell skincare, toothpaste and toys, too